ore than a 50% run higher for the stock since February. Reiterating a Buy rating and boosting the price target to $24 from $20 (30%+ upside), UBS's Brennan Hawken is impressed with how much money Apollo put to work in Fund VIII Q3, thus allowing fundraising to get going for Fund IX. Importantly, Apollo isn't